Multipharma
ActiveSummary
Multipharma has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €128.1m and a net result of -€2.9m. Equity is growing by ~4.3% per year across the filed fiscal years. Its solvency ranks better than 61% of 4911 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- Other statement: Intern vastgestelde en door raad van bestuur goedgekeurde bevoegdheidsdelegaties en bestuursregels, bepaalde beslissings-en…
Read from the deeds: 1 provision, deed of 23-06-2026